
×
„The book is the first galectin book and contains a wealth of information. The chapters provide researchers with a solid overview of the state of the art in the various subjects and will be useful to many galectin researchers.“ (ChemBioChem, January 2009)
„A comprehensive guide to the current understanding of galectins, their promising potential in drug design.“ (Forbes, June 2008)
The comprehensive guide to the current understanding of galectins and their promising potential in drug design
This is the first book focusing on galectins. It was inspired by topics discussed at the symposium „Galectins: Structures, Functions, and Therapeutic Targets“ that was a part of the 234th American Chemical Society meeting in 2007. To help chemists, biochemists, and others understand the challenges inherent in the study of galectins and build on recent advances in the field, the editors have compiled articles from leading experts on galectins and their biomedical applications. Galectins includes:
This is the premier reference on galectins for organic, medicinal, carbohydrate, and pharmaceutical chemists, biochemists, molecular and cell biologists, pharmacologists, cancer researchers, and graduate-level students in these disciplines, as well as clinicians and drug developers.
This is the first book focusing on galectins. It was inspired by topics discussed at the symposium „Galectins: Structures, Functions, and Therapeutic Targets“ that was a part of the 234th American Chemical Society meeting in 2007. To help chemists, biochemists, and others understand the challenges inherent in the study of galectins and build on recent advances in the field, the editors have compiled articles from leading experts on galectins and their biomedical applications. Galectins includes:
This is the premier reference on galectins for organic, medicinal, carbohydrate, and pharmaceutical chemists, biochemists, molecular and cell biologists, pharmacologists, cancer researchers, and graduate-level students in these disciplines, as well as clinicians and drug developers.